144 related articles for article (PubMed ID: 32502031)
1. Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer: A meta-analysis.
Zang Y; Fan Y; Gao Z
Medicine (Baltimore); 2020 Jun; 99(23):e20595. PubMed ID: 32502031
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.
Fan Y; Xiang S; Dai Z; Zou C; Wang X; Gao Z
Int J Colorectal Dis; 2019 Jun; 34(6):1105-1111. PubMed ID: 31016379
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein/albumin ratio is a prognostic indicator in Asians with pancreatic cancers: A meta-analysis.
Fu YJ; Li KZ; Bai JH; Liang ZQ
Medicine (Baltimore); 2019 Nov; 98(48):e18219. PubMed ID: 31770284
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patients.
Hang J; Xue P; Yang H; Li S; Chen D; Zhu L; Huang W; Ren S; Zhu Y; Wang L
Sci Rep; 2017 Jun; 7(1):2993. PubMed ID: 28592881
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis.
Yu J; Liu H; Zeng X; Zhao Y; Jiang D; Lu H; Qian J
PLoS One; 2021; 16(4):e0250295. PubMed ID: 33901218
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
Wu D; Wang X; Shi G; Sun H; Ge G
Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
Yang X; Song X; Zhang L; Wu C
Medicine (Baltimore); 2020 Mar; 99(10):e19362. PubMed ID: 32150079
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta analysis.
Wang F; Li P; Li FS
Medicine (Baltimore); 2019 Jul; 98(29):e16064. PubMed ID: 31335668
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.
Liu Z; Shi H; Chen L
BMC Cancer; 2019 Nov; 19(1):1161. PubMed ID: 31783812
[TBL] [Abstract][Full Text] [Related]
12. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
Wu M; Guo J; Guo L; Zuo Q
Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of C-reactive protein to albumin ratio in metastatic colorectal cancer: A systematic review and meta-analysis.
Pan Y; Lou Y; Wang L
Medicine (Baltimore); 2021 Nov; 100(46):e27783. PubMed ID: 34797305
[TBL] [Abstract][Full Text] [Related]
14. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of the C-reactive protein to albumin ratio in cancer: An updated meta-analysis.
Cui X; Jia Z; Chen D; Xu C; Yang P
Medicine (Baltimore); 2020 Apr; 99(14):e19165. PubMed ID: 32243358
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
Deng TB; Zhang J; Zhou YZ; Li WM
Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
[TBL] [Abstract][Full Text] [Related]
18. The Predictive Value of the CRP-to-Albumin Ratio for Patients With Pancreatic Cancer After Curative Resection: A Retrospective Single Center Study.
Vujic J; Marsoner K; Wienerroither V; Mischinger HJ; Kornprat P
In Vivo; 2019; 33(6):2071-2078. PubMed ID: 31662540
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
Liao CK; Yu YL; Lin YC; Hsu YJ; Chern YJ; Chiang JM; You JF
World J Surg Oncol; 2021 May; 19(1):139. PubMed ID: 33933070
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis.
Xie Q; Wang L; Zheng S
Dose Response; 2020; 18(2):1559325820931290. PubMed ID: 32647499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
